A narrative review synthesizing evidence on a proposed reclassification framework for diabetes; provides conceptual guidance on personalized treatment approaches but does not present original efficacy data or comparative clinical outcomes.
A retrospective case-control study identifying first-trimester metabolic markers predictive of GDM with moderate diagnostic accuracy (AUC 0.849 for combined model), but lacking prospective validation, blinding, or hard clinical outcome data to support practice change.